Abstract
Background: Unicondylar knee arthroplasty (UKA) are being expanded to include younger patients with more active lifestyles because of its minimally invasive nature. Prior to expanding this role, it is important to examine mode of failure and implication of conversion to TKA in the low demand elderly patients.
Aim: To ascertain the modes of early failure of unicondylar knee Arthroplasty and assess whether the conversion to TKA improved the functional scores, range of motion, pain, and patient satisfaction.
Method: A retrospective study to evaluate the results of 14 revision procedures after failed unicompartmental knee arthroplasty (UKA). Patients’ operative charts were reviewed. Details of modes of failure, technical difficulty of revision including exposure, component removal, and management of bone loss were noted. Post operative functional outcome was assessed using WOMAC osteoarthritis index and SF-36.
Result: Total of 106 primary unicondylar knee arthroplasty procedures was performed between 2003 and 2007 in our institution. Oxford unicondylar implant was used in all patients. 13.21% of these were revised to total knee replacement. Revisions were performed 4 months to 36 months after the primary procedure; 86% of these were required within the first 12 months. The average time to failure was 15.6 months.
The modes of failure were aseptic loosening (4), progression of osteoarthritis (2), instability (3), infection (2), dislocated insert (1) and persistent pain after UKA (2). Tibia insert exchange was done in one patient and the rest were converted to primary Scorpio and PFC components. Three of the patients had significant defect in femoral condyle. Fourteen percent of cases required femoral stem extension or metal wedge augmentation.
Nine of the 14 knees (64%) were followed up for an average of 15 months. The mean WOMAC and SF-36 scores at latest follow up were 33.33 and 63.79 respectively.
Conclusion: Despite the advantage of minimally invasive UKA, early failure can occur in the face of good surgical technique. The higher long-term success rate claimed by implant manufacturer is challengeable and patient should be informed during consent.
Correspondence should be addressed to Mr Richard Wallace at Musgrave Park Hospital, 20 Stockman’s Lane, Belfast BT9 7JB, Northern Ireland.